Before revision:  Taking a genome-scale, systems-level view of virus-host interactions, we adapt and specialize network label propagation methods to prioritize drug targets based on their probability to inhibit host-pathogen interactions or their downstream signaling targets.
After revision:  Taking a genome-scale, systems-level computational approach to prioritize drug targets based on their probability to inhibit host-pathogen interactions or their downstream signaling targets.